Ferring Research Institute

AI, IBD, drug discovery
Israeli startup CytoReason joins forces with Ferring Pharmaceuticals to find new IBD treatment
By Tammy Lovell | 04:56 am | May 19, 2021
The collaboration will use AI technology to accelerate the drug discovery process.